Miraclare

Based in Gyeongsangnam-do, South Korea, Miraclare develops innovative AI-powered dental home care products aimed at enhancing oral health and addressing issues like sleep bruxism. Miraclare, founded in 2022, specializes in AI-based solutions for dental health. The company has received KRW 300 million in funding from the Korea SMEs and Startups Agency to support its operations. It has conducted one deal as of May 12, 2026, during which it raised this total amount.

The details of its inception do not mention any pivots or changes in strategy, nor does it indicate any parent or subsidiary relationships. The founder's background is not detailed, so it's unclear if they have prior entrepreneurial experience. Miraclare specializes in AI-based dental home care products, focusing on innovative solutions that enhance dental health through advanced technology. Their core offerings include the goodeeps monitoring system, a hospital-grade wearable device that tracks temporalis muscle activity during sleep to address sleep bruxism; goodeeps, a health care product aimed at relieving sleep bruxism and teeth clenching; and goodbite, a device designed to improve chewing habits by monitoring and providing real-time feedback on chewing data.

These products provide insights and promote awareness around unconscious dental habits among patients and dental professionals. Miraclare primarily targets markets in South Korea, Japan, and Taiwan, with plans for expansion into Hong Kong and Macau. The end users include individuals suffering from bruxism and those seeking to improve their chewing efficiency, as well as dental professionals looking for reliable data for treatment planning. Miraclare's revenue model is based on direct-to-consumer sales and B2B relationships with dental professionals and clinics.

The company generates income through retail and wholesale channels, with flagship products such as goodeeps and goodbite. Sales transactions typically involve one-time purchases with optional subscriptions for continued data analytics and monitoring through associated smartphone applications, catering to both consumers and dental practices. In May 2026, Miraclare raised KRW 300 million in venture funding from Korea SMEs and Startups Agency, which will be utilized to pursue global regulatory approval for the goodeeps device, an EMG-based medical solution for sleep bruxism. The company aims to expand its distribution network to major hospitals in Korea and is also targeting further market entries in Hong Kong and Macau.